Dr. Cush
Rheumnow Podcast
Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com
Be sure to visit the podcast's website and support the creator: rheumnow.podbean.com
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Mentshlichkeit (8.7.2026) 07.08.2026 22:31
Dr. Jack Cush reviews the news and recent journal reports on RheumNow.com
A JAKi After TNFi Failure in RA: SELECT-SWITCH at Week 12 03.08.2026 25:48
Dr. Christina Charles-Schoeman and Dr. Manish Jain are back to discuss treatment considerations after TNFi failure in RA. Join them as they review the latest data from SELECT-SWITCH, including post hoc results in primary and secondary nonresponders presented at EULAR 2026. Learn how those findings impact their clinical decision-making. Sponsored by AbbVie Medical Affairs + Health Impact
TU: Systemic Burden of Gout Part 2 (24 plus) 01.08.2026 29:23
Dr. Jack Cush Obesity & Gout Dr. Tony Merriman Genome-Wide Association Studies in Gout Dr. Lisa Stamp Gout Management in Patients with Chronic Kidney Disease Dr. Mark Fisher Gout & Mortality
Methotrexate Safety Tips (7.31.2026) 31.07.2026 20:16
Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com
Gout Lessons from the Clinic Part 3 30.07.2026 28:33
Dr. Sheila Reyes: QD Clinic: The Highs and Lows of a Woman with Gout Dr. Jack Cush QD319 A Watched Tophus Never Resolves Dr. Eric Dein QD316: Addressing Severe Gout Flares Dr. Janet Pope QD Clinic: RA Mimics — Two Cases That Turned Out to Be Gout
DERM on RheumNow (July 2026) 29.07.2026 10:39
The Derm on RheumNow podcast is a review of recent citations and content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, CTD skin disorders. dermatology drugs, biologics, andJAK inhibitors - their use, efficacy and side effects. Features Dr. Jack Cush, Editor at RheumNow.com. Show Notes: - 20 yr. Tx trends in 6583 #SSc pts. 2005 to 2025 endothelin receptor antagonists...
New, Advanced Therapies in Gout 29.07.2026 1:01:25
New, Advanced Therapies in Gout explores the rapidly evolving therapeutic landscape beyond conventional urate-lowering therapy. Join our expert panel as they discuss emerging approaches—including cytokine inhibition, uricase therapies, NLRP3 and URAT-1 inhibitors, and the potential role of GLP-1 receptor agonists and SGLT2 inhibitors—while addressing which patients are most likely to benefit, how...
Systemic Burden of Gout Part 1 29.07.2026 34:09
Dr. Robert Terkeltaub 3 New Things it Pays to Know About Gout Pathobiology Dr. Nicola Dalbeth Outcomes of Tophaceous Gout Dr. Ted Mikuls Subclinical Inflammation in Intercritical Gout Dr. Michael Pillinger Gout and Cardiovascular Disease: What's the Risk? What's the Connection?
Better Gout Management 29.07.2026 19:43
Dr. John Fitzgerald Gout & Metabolic syndrome Dr. Karon Jatuworpruk Predicting and managing gout flares in hospitalised patients Dr. Richard Conway Bespoke Telehealth in Gout: A Missed Opportunity
Gout Advice & Tips 29.07.2026 24:21
Dr. Robert Terkeltaub Four things you need to know about allopurinol hypersensitivity syndrome Dr. Angelo Gaffo Challenges in Gout Diagnosis Dr. Janet Pope Tips for safe use of allopurinol in patients with gout
Gout Lessons from the Clinic Part 2 29.07.2026 30:59
Dr Janet Pope: QD Clinic: Can RA and Gout Manifest Simultaneously? Dr. Mrinalini Dey QD312: Gout, Sepsis… or Both? Daric Mueller, PA-C QD315: Pegloticase Immunomodulation: What’s on the Menu? Dr. Richard Conway: QD313: Don't Presume on IL-1 in Gout
Chikungunya Club Meeting (7.24.2026) 24.07.2026 29:40
Dr. Jack Cush reviews the news, journal reports from the past week on RheumNow.com
Upgrading & Maximizing the Classics (Colchicine, Allopurinol, etc.) 22.07.2026 1:05:37
Upgrading & Maximizing the Classics (Colchicine, Allopurinol, etc.) examines how to optimize the use of time-tested gout therapies in today's increasingly complex patients. Through practical case discussions, our expert faculty will address colchicine safety and dosing in chronic kidney disease, selecting first-line therapy for acute flares, initiating and titrating urate-lowering therapy, imp...
Seronegative RA Disease Activity (7.17.2026) 17.07.2026 21:27
Dr. Jack Cush reviews the news, journal articles and Gout features from this past week on RheumNow.com
What Lies Beneath - Uric Acid Deposition & Imaging 15.07.2026 59:52
This webinar explores the evolving role of imaging in the diagnosis and management of gout. Our expert panel will discuss when and how to use ultrasound, dual-energy CT (DECT), crystal identification, and conventional radiography, while addressing practical questions such as the role of imaging in diagnostic uncertainty, serial disease monitoring, and whether ultrasound is changing the need for sy...
Gout QD clinics - lessons from the Clinic QD307-QD311 13.07.2026 38:00
QD307: Senior Year Gout https://youtu.be/_TGgcdQsfic QD308: Allopurinol for All Gout? Not Quite https://youtu.be/JAwUb-hqeFs QD309: Cellulitis Paradoxes https://youtu.be/j3feySk5wQo QD310: Gout: Is it the Journey or the Destination? https://youtu.be/1J-ZrbaGsD8 QD311: When There's Doubt in Gout https://youtu.be/DpAevfq7Oo0
Gout Cavalcade (7.10.2026) 10.07.2026 27:13
Dr. Jack Cush reviews the news, journal articles and regulatory decisions from the past week. July is Gout: More than Flares month. Visit https://rheumnow.com/campaign/gout-campaign-july-2026 for all of our coverage throughout July.
Gout Journal Club 08.07.2026 57:26
Gout Journal Club will examine two influential publications: 1. "Treat-to-Target Urate-Lowering Treatment and Cardiovascular Outcomes in Patients with Gout" (Cipolletta et al., JAMA Internal Medicine, 2026) and 2. "Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease"(Wang et al., JAMA Internal Medicine, 2025). Together, these studies provi...
Podcast Replay: Is it Time to Transition MOAs in RA? 07.07.2026 17:16
In August, Dr. Christina Charles-Schoeman and Dr. Manish Jain will return with a new episode exploring the latest clinical data on RA treatment after TNFi failure. Before that episode drops, revisit their 2025 conversation on disease control, real-world data, and guidelines that inform clinical decision-making after TNFi failure. Sponsored by AbbVie Medical Affairs + Health Impact.
ICYMI: Great Lectures; Great Presentations 03.07.2026 27:45
Dr. Jack Cush lectures on giving a great presentation; based on 40 years of lecturing in Rheumatology.
Generic Tofacitinib (6.26.2026) 26.06.2026 30:23
Dr. Jack Cush reviews the news and journal articles from RheumNow.com. Updates on tofacitinib, CAR-T therapy and AI.
DERM on RheumNow (June 2026) 26.06.2026 17:43
The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use, efficacy and side effects. Features Dr. Jack Cush, Editor at RheumNow.com. Show Notes: - Breckenridge Pharmaceutical received FDA approval for their generic version of tofacitini...
Do You Zoster Vaccinate? (6.19.2026) 19.06.2026 29:24
Dr. Jack Cush reviews the news, journal reports and best ways to review EULAR 2026.
RheumNow EULAR 2026 Rheumatology Round Up 12.06.2026 56:02
Drs. Jack Cush & Arthur Kavanaugh, two of rheumatology’s most trusted voices, provide a breakdown of the latest breakthroughs and hottest topics in rheumatology from the EULAR 2026 meeting in London.
EULAR 2026 RA Topic Panel 11.06.2026 54:22
Join Drs. Bella Mehta, Jack Cush, Janet Pope, and Jon Kay for a focused conversation on the latest in rheumatoid arthritis care from emerging data and treatment strategies to real-world challenges in diagnosis and management. Hear expert perspectives, clinical pearls, and what’s shaping RA practice right now.
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.